Neuberger Berman Group LLC Bristol Myers Squibb CO Transaction History
Neuberger Berman Group LLC
- $121 Billion
- Q4 2024
A detailed history of Neuberger Berman Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Neuberger Berman Group LLC holds 2,650,872 shares of BMY stock, worth $158 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
2,650,872
Previous 1,801,412
47.16%
Holding current value
$158 Million
Previous $93.2 Million
60.83%
% of portfolio
0.12%
Previous 0.08%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,760Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.3 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.46 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.72 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.67 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.6 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $127B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...